Salix Pharmaceuticals, Inc.
Manufacturer / marketing-authorisation holder
Salix Pharmaceuticals, Inc. — 18 products across 2 markets, 11 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Salix Pharmaceuticals, Inc. — 18 productos en 2 mercados, 11 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Salix Pharmaceuticals, Inc. —— 共 18 个产品，覆盖 2 个市场、11 个品牌名。产品按国家分组；品牌名链到品牌页，成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」，不一定是生产工厂。
18 products · 2 markets · 11 brand names
18 productos · 2 mercados · 11 marcas
18 个产品 · 2 个市场 · 11 个品牌名
Products by country
US
Source: api.fda.gov
| Brand | Active ingredient(s) | Form |
|---|---|---|
| APRISO | Mesalamine | capsule |
| Anusol HC | 氢化可的松 | suppository |
| Anusol HC | 氢化可的松 | topical |
| DIURIL | Chlorothiazide | liquid |
| MoviPrep | Ingredient not recorded (name-level) | kit |
| Plenvu | Ingredient not recorded (name-level) | kit |
| Proctocort | 氢化可的松 | suppository |
| Relistor | Methylnaltrexone | injection |
| Relistor | Methylnaltrexone | tablet |
| Relistor | Methylnaltrexone | injection |
| Trulance Immediate release | Plecanatide | tablet |
| Uceris | 布地奈德 | topical |
| XIFAXAN | 利福昔明 | tablet |
| XIFAXAN | 利福昔明 | tablet |
CA
Source: health-products.canada.ca
| Brand | Active ingredient(s) | Form |
|---|---|---|
| Relistor | Methylnaltrexone | liquid |
| Relistor | Methylnaltrexone | liquid |
| Relistor | Methylnaltrexone | liquid |
| ZAXINE | 利福昔明 | tablet |